Abiomed Inc (NASDAQ:ABMD)

181.69
Delayed Data
As of 4:00pm ET
 -7.53 / -3.98%
Today’s Change
155.02
Today|||52-Week Range
364.31
-44.10%
Year-to-Date
Is Abiomed a Bad-News Buy Right Now?
Dec 04 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close189.22
Today’s open189.30
Day’s range179.54 - 189.83
Volume764,077
Average volume (3 months)726,253
Market cap$8.6B
Data as of 4:00pm ET, 12/09/2019

Growth & Valuation

Earnings growth (last year)+127.01%
Earnings growth (this year)-19.93%
Earnings growth (next 5 years)+23.00%
Revenue growth (last year)+29.59%
P/E ratio37.9
Price/Sales17.13
Price/Book9.15

Competitors

 Today’s
change
Today’s
% change
WSTWest Pharmaceutical ...-2.74-1.86%
HAEHaemonetics Corp-3.76-3.10%
PENPenumbra Inc-6.60-3.93%
PODDInsulet Corp-3.30-1.79%
Data as of 6:30pm ET, 12/09/2019

Financials

Next reporting dateJanuary 30, 2020
EPS forecast (this quarter)$1.09
Annual revenue (last year)$769.4M
Annual profit (last year)$259.0M
Net profit margin33.66%

Profile

Sector
Health Technology
Industry
Medical Specialties
No executives to display
Corporate headquarters
Danvers, Massachusetts

Forecasts